Safety of topical 5-aminosalicylic acid in pregnancy

American Journal of Gastroenterology

Volumn 92, Issue 12 SUPPL., 1997, Pages 2201-2202

  Bell, Chaim M ^b   Habal, Flavio M ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; DESCENDING COLON; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; PREGNANCY; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ABNORMALITIES, DRUG-INDUCED; ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS; COLON; ENEMA; FEMALE; FERTILIZATION; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MESALAMINE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RECURRENCE; SAFETY; SUPPOSITORIES; TREATMENT OUTCOME;

EID: 0030734788     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Korelitz BI. Pregnancy, fertility and inflammatory bowel disease. Am J Gastroenterol 1985;80:365-70.
2. Nielsen OH, Andreasson B, Bondesen S, et al. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983;18:735-42.
3. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: A controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989;160:998-1001.
4. Miller JP. Inflammatory bowel disease in pregnancy: A review. J R Soc Med 1986;79:221-5.
5. Habal FM, Hui G, Greenberg GR. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: Safety and clinical course. Gastroenterology 1993;105:1057-60.
6. Trallori G, d'Albasio G, Bardazzi G, et al. 5-aminosalicylic acid in pregnancy: Clinical report. Ital J Gastroenterol 1994;26:75-8.
7. Azad Khan AK, Howes DT, Piris J, et al. Optimum dose of sulfasalazine for maintenance treatment in ulcerative colitis. Gut 1980;21:232-40.
8. Zeldis JB. Pregnancy and inflammatory bowel disease. West J Med 1989;151:168-71.
9. Mogadam M, Dobbins W III, Korelitz BI, et al. Pregnancy in inflammatory bowel disease: Effect of sulfasalazine on fetal outcome. Gastroenterology 1981;80:72-6.
10. Singleton JW, Law DH, Kelly LM Jr, et al. National Cooperative Crohn's Disease Study: Adverse reactions to study drugs. Gastroenterology 1979;77:870-82.
11. Das KM, Eastwood MA, McManus P, et al. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 1973;289:491-5.
12. Taffet SL, Das KM. Sulfasalazine: Adverse effects and desensitization. Dig Dis Sci 1983;28:833-42.
13. Mulder CJ, Tytgat GN, Weterman IT, et al. Double blind comparison of slow- release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology 1988;95:1449-53.
14. Prantera C, Pallone F, Brunetti G, et al. Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. Gastroenterology 1992;103:363-8.
15. Colombel J-F, Brabant G, Gubler M-C, et al. Renal insufficiency in infant: Side effect of prenatal exposure to mesalamine? Lancet 1994; 344:620-1.
16. Christensen LA, Rasmussen SN, Hansen SH. Disposition of 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid in fetal and maternal body fluids during treatment with different 5-aminosalicylic acid preparations. Acta Obstet Gynecol Scand 1994;74:399-402.
17. Marteau P, Devaux CB. Mesalamine during pregnancy. Lancet 1994; 344:1708-9.
18. Campieri M, Lanfranchi GA, Boschi S, et al. Topical administration of 5- aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Gut 1985;26:400-5.
19. Biddle WL, Greenberger J, Swan T, et al. 5-aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 1988;94:1705-9.
20. Guarino J, Chatzinoff M, Berk T, et al. 5-aminosalicylic acid enemas in refractory distal ulcerative colitis: Long-term results. Am J Gastroenterol 1987;82:732-7.
21. Hanauer SB, Schultz PA. Relapse rates after successful treatment of refractory colitis with 5-ASA enemas. Gastroenterology 1987;92:1424.